EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

Blood

ISSN 0006-4971 · American Society of Hematology

Frequent topics

HOXAT-cell acute lymphoblastic leukemiaTLX1TLX3WT1 mutationschromosomal deletionpediatric leukemiaprognostic valuerelapsetumor suppressor

Latest articles

  1. Microbiota-derived short-chain fatty acids control cGVHD development by regulating antibody production

    Alex E Wolfe, Tam Ho, Saranya Rani Chakka, Albert C Yeh, Mercy Mirimo-Martinez, Shruti S. Bhise, Yvonne Hsu, Alison A Notestine, Felix Pahmeier, Jillian R Jaycox, Huiqi Wang, Giulia E Stewart, Raisa Glabman, Ali Turan, Romina Ghale, Jonathan U. Peled, Shijie Cao, Geoffrey R Hill, Aaron M Ring, Marcel R.M. van den Brink, Scott N. Furlan, Kate A Markey

    Published: 2026-11-16DOI: 10.1182/blood.2026034453

  2. Etentamig in Relapsed/Refractory Multiple Myeloma: Pooled Phase 1 Data of an Investigational BCMA Bispecific Antibody

    Muhamed Baljevic, Peter Voorhees, Cesar Rodriguez, Anita D'Souza, Alfred Chung, Eben Isaac Lichtman, Hana Safah, Katja C Weisel, Ravi Vij, Hira Mian, Hila Magen, Emma Searle, John T. Mckay, Neha S. Korde, Saurabh Chhabra, Anders Svensson, Rajvineeth Kumar Pothacamury, Chetasi Talati, Carli Allendorf, Claudie Hecquet, Valerie Robinson, Aarif Ahsan, Shaji K. Kumar

    Published: 2026-11-16DOI: 10.1182/blood.2026034590

  3. Carfilzomib-based strategies in transplant-eligible multiple myeloma: long-term follow-up of the phase 2 FORTE trial

    Giuseppe Bertuglia, Mattia D'Agostino, Delia Rota-Scalabrini, Angelo Belotti, Laura Paris, Micol Quaresima, Sonia Morè, Stelvio Ballanti, Sara Aquino, Paolo De Fabritiis, Francesca Fioritoni, Michele Cea, Nicola Giuliani, Francesca Patriarca, Stefania Oliva, Massimo Gentile, Francesca Fazio, Renato Zambello, Sara Bringhen, Paolo Corradini, Benedetto Bruno, Elena Zamagni, Mario Boccadoro, Pellegrino Musto, Francesca Gay

    Published: 2026-11-16DOI: 10.1182/blood.2026035635

  4. Aligning Clinical Trial Reporting: A systematic analysis and position statement by the International Consortium for MDS

    Andrew M. Brunner, Ted M. Getz, Kelly Pugh, Jan Philipp Bewersdorf, Tariq Kewan, Uma Borate, Amy E DeZern, Uwe Platzbecker, Mikkael A Sekeres, Andrew H Wei, Rena J. Buckstein, Gail J. Roboz, Michael R Savona, Sanam Loghavi, Robert P Hasserjian, Pierre Fenaux, David A Sallman, Christopher S Hourigan, Matteo Giovanni Della Porta, Stephen D Nimer, Richard F. Little, Valeria Santini, Fabio Efficace, Justin Taylor, Olatoyosi Odenike, Tae Kon Kim, Stephanie Halene, Rami S. Komrokji, Elizabeth A. Griffiths, Peter L. Greenberg, Mina L. Xu, Zhuoer Xie, Rafael Bejar, Guillermo Sanz, Mrinal M. Patnaik, Maria E Figueroa, Hetty E Carraway, Omar Abdel-Wahab, Daniel T Starczynowski, Eric Padron

    Published: 2026-11-13DOI: 10.1182/blood.2026035348

  5. CD70 overexpression at diagnosis predicts relapse and supports dual CD19-CD70 CAR T-cell therapy in follicular lymphoma

    Ferran Araujo-Ayala, Maria Ros, Raluca Alexandru, Judith Mateos-Jaimez, Alba Rodriguez-Garcia, Marta Giménez-Alejandre, María Villalba-Esparza, Pablo Mozas, Guillem Colell, Salut Colell, Mireia Bachiller, Ferran Nadeu, Andrea Rivero, Ariadna Giró, Daniel J. Hodson, Soumya Poddar, Armando López-Guillermo, Dolors Colomer, Alba Maiques-Diaz, José Ignacio Martín-Subero, Sílvia Beà, Laura Magnano, Mitchell R. Smith, Álvaro Urbano-Ispizua, Julio Delgado, Manel Juan, Elías Campo, Carlos E. De Andrea, Sonia Guedan, Patricia Pérez-Galán

    Published: 2026-11-12DOI: 10.1182/blood.2025032663

  6. Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004

    William G. Wierda, Kathleen Dorritie, Jordan Gauthier, Rajneesh Nath, Thomas J. Kipps, Peter A. Riedell, Herbert A. Eradat, Saad S. Kenderian, Mohamed A. Kharfan-Dabaja, Nirav N. Shah, Scott R. Solomon, Deborah M. Stephens, Daniel A. Ermann, Jon Arnason, Abhinav Deol, Tatyana Feldman, Charalambos Andreadis, Monalisa Ghosh, Shuo Ma, Stephen J. Schuster, Usama Gergis, Julie M. Vose, Jacob Soumerai, Koen van Besien, Sherilyn A. Tuazon, Serena K. Perna, San-San Ou, Revathi Ananthakrishnan, Neha Rane, Eniko Papp, Sahar Ansari, Ethan G. Thompson, Abood Okal, Leanne Peiser, Yizhe Chen, Sanhita Sengupta, Pradipta Ray, Jixian Wang, Tanya Siddiqi

    Published: 2026-11-12DOI: 10.1182/blood.2026033565

Volumes

2026 · 9532025 · 9,1932024 · 8,8242023 · 8,2682022 · 7,0522021 · 5,8972020 · 5,0902019 · 6,7762018 · 6,8782017 · 1,5302016 · 7,1882015 · 6,8932014 · 7,3302013 · 6,9972012 · 6,9272011 · 7,3502010 · 6,9352009 · 6,9722008 · 7,1562007 · 6,8042006 · 7,0672005 · 7,1102004 · 6,8452003 · 1,6812002 · 1,5022001 · 1,2742000 · 2,0851999 · 1,7411998 · 2,1601997 · 1,6761996 · 1,6011995 · 1,3441994 · 2,0691993 · 1,9891992 · 1,9231991 · 1,7741990 · 1,5291989 · 1,4921988 · 1,2541987 · 1,192

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.